Navigation Links
febit Forms Scientific Advisory Board
Date:3/31/2008

Five renowned researchers to guide febit's research and business

development activities

MEDFORD, Mass. and HEIDELBERG, Germany, March 31 /PRNewswire/ -- febit group, the provider of the unique microfluidic microarray system Geniom, today announced the formation of a Scientific Advisory Board (SAB) consisting of leading authorities at the forefront of genetics and genomics research. The SAB members, from top research institutions and companies, will provide expert advice on febit's research and development activities associated with its portfolio development.
The interdisciplinary febit Scientific Advisory Board consists of:

-- Mark Chee, Ph.D., who will serve as chairman. As a former scientist of

Affymetrix and co-founder of Illumina (ILMN) he has an exceptional

knowledge of microarray technologies and market.

-- Karoly Nikolich, Ph.D., who will serve as vice chairman. Dr. Nikolich

was formerly the executive director of the Neuroscience Institute of

Stanford. He is an entrepreneur and consultant, and has over 20 years

of biotechnology industry experience in R&D.

-- David Lockhart, Ph.D., the CSO of Amicus Therapeutics. Dr. Lockhart

brings many years of industry experience and achievements, including

credit as the primary inventor and developer of genome-wide

gene-expression profiling with high-density DNA arrays when he was at

Affymetrix.

-- Mostafa Ronaghi, Ph.D., one of the inventors of Pyrosequencing,

molecular inversion probe assay and Nextbio search engine. He has

co-founded four companies and serves on the board of director and

scientific advisory board of several companies.

-- Jeffrey Trent, Ph.D., the president and scientific director of the

Translational Genomics Research Institute (TGen) in Phoenix, Ariz. In

addition to his expertise in cDNA-microarray, Dr. Trent was one of the

leading scientists with the "Human Genome Project."

"The formation of febit's scientific advisory board brings together key thought leaders with deep insight into the needs of the scientific community in genomic research," said Cord F. Staehler, CEO of febit holding gmbh. "We look forward to their support and guidance that will help us realize the full potential of febit's portfolio of unique applications for existing and future strategic partnerships."

Dr. Chee added, "It is our goal to help febit meet scientists' needs and open up new possibilities in genomic research. febit's Geniom technology is a unique tool for various applications in this field from microarray analysis to synthetic biology."

About febit

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology and services, febit is the only company that puts the control of simplified genomic research in the hand of the user. The seamless integration of DNA synthesis and analysis and the superior support in experiment design and bioinformatics helps to understand data and turn it into results. febit's team of experienced scientists is dedicated to support customers to solve the challenge of understanding biological processes. Geniom is a technological and service platform successfully implemented in basic and applied research by renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications. http://www.febit.com

Contact:

febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manager +1-212-845-4271

+49 (6221) 6510-300 david.schull@russopartnersllc.com

eva.sterzel@febit.de wendy.lau@russopartnersllc.com


'/>"/>
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
2. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
3. Technology Transforms Market Research in Pharmaceutical Industry
4. Anthera Pharmaceuticals Forms Scientific Advisory Board
5. Transgenomic, Inc. Forms Scientific Advisory Board
6. ADM Forms Industrial Chemicals Group
7. iGuard Transforms Drug Safety Alert and Update Process
8. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
9. NASA technology forms the basis for a new nanotechnology company
10. Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program
11. Boston Scientific Announces Schedule for ACC 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... Flagship Biosciences, the leader ... to its Board of Directors. Dr. Gillett recently retired from Charles River Laboratories ... and Chief Scientific Officer. A board-certified veterinary pathologist, Dr. Gillett joined Charles River ...
(Date:5/3/2016)... May 3, 2016  Dr. Thomas P. McHugh ... The Woodlands, Texas , now offers ... of treated fat cells in just 25-minutes, leaving a ... 90 percent of Americans report feeling bothered by excess ... reduction procedures are a growing industry. This innovative new ...
(Date:5/2/2016)... Ohio (PRWEB) , ... May 02, 2016 , ... ... Designed with its clients in mind, the fresh look and added functionality give ... , “Recent years have seen a dynamic shift in agriculture – from precision ...
(Date:4/29/2016)... ... 29, 2016 , ... Proove Biosciences, Inc ., the ... launch of the Proove Health Foundation . The Foundation is a non-profit ... use of personalized medicine for tackling the nation’s most-pressing healthcare epidemics. As part ...
Breaking Biology Technology:
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):